Business Segments West Pharmaceutical Services, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 07:35:50 20/05/2026 pm IST			5-day change	1st Jan Change
302.65 ^USD	-0.42%		+0.68%	+10.66%

16/05	West Pharmaceutical says making progress in restoring global operations after cyberattack	RE
15/05	West Pharma says operations recovering after cyberattack	RE

Breakdown by Business Segment (USD)

Fiscal Period: December	2021	2022	2023	2024	2025
Medical Instruments
Proprietary Products	231.73Cr	240.68Cr	239.73Cr	233.45Cr	249.21Cr
Total Assets	215.26Cr	257.83Cr	262.91Cr	262.11Cr	298.7Cr
CAPEX	-22Cr	-24Cr	-26Cr	-25Cr	-20Cr
Gross Profit	109.39Cr	105.33Cr	103.4Cr	90Cr	100.82Cr
D&A	9.38Cr	9.69Cr	11Cr	13Cr	14Cr
Operating Income	80Cr	78Cr	71Cr	58Cr	66Cr
West Vantage	51Cr	48Cr	55Cr	56Cr	58Cr
Total Assets	44Cr	48Cr	53Cr	61Cr	72Cr
CAPEX	-2.66Cr	-3.4Cr	-9.02Cr	-12Cr	-7.55Cr
Gross Profit	8.38Cr	8.29Cr	9.6Cr	9.8Cr	9.58Cr
D&A	2.11Cr	1.9Cr	2.04Cr	2.13Cr	2.79Cr
Operating Income	6.72Cr	6.04Cr	7.21Cr	7.23Cr	6.34Cr
Corporate and Unallocated	-4L	-3L	-	-	-
Total Assets	72Cr	56Cr	67Cr	41Cr	56Cr
CAPEX	-88L	-1.33Cr	-1.27Cr	-95L	-61L
D&A	74L	47L	40L	38L	33L
Operating Income	-	-	-	-	-
Operating Income	-3.75Cr	-2.37Cr	-2.33Cr	-1.87Cr	-2.38Cr
Operating Income	-6.34Cr	-5.91Cr	-6.83Cr	-5.86Cr	-7.44Cr
Gross Profit	-19L	-	-8L	-	-

Geographical breakdown of sales (USD)

Fiscal Period: December	2021	2022	2023	2024	2025
United States	119.8Cr	128.65Cr	123.85Cr	123.08Cr	132.96Cr
Total Assets	50Cr	61Cr	76Cr	83Cr	83Cr
Other European Countries	34Cr	36Cr	39Cr	39Cr	45Cr
Total Assets	6.51Cr	8.18Cr	9.92Cr	9.81Cr	11Cr
Germany	47Cr	40Cr	41Cr	37Cr	38Cr
Total Assets	12Cr	14Cr	18Cr	19Cr	23Cr
Other	36Cr	36Cr	35Cr	34Cr	35Cr
Total Assets	16Cr	18Cr	19Cr	21Cr	22Cr
Ireland	25Cr	24Cr	29Cr	32Cr	33Cr
Total Assets	19Cr	18Cr	21Cr	30Cr	37Cr
France	21Cr	24Cr	28Cr	24Cr	23Cr
Total Assets	8.61Cr	6.88Cr	7.85Cr	8.47Cr	11Cr